Corbus Pharmaceuticals (CRBP) AGM 2026 summary

Opening remarks and agenda

• The meeting was opened by the Chair, who introduced board members, executive officers, legal counsel, and the independent accounting firm present for the session.

• The meeting was held remotely, and validated stockholders were invited to submit questions via the web portal, limited to three per person.

• Only the five proposals outlined in the proxy statement were eligible for voting, as no additional stockholder proposals were submitted in advance.

Corporate governance

• The record date for voting was March 23, 2026, with 17,736,464 shares outstanding and a quorum established with 14,134,370 shares represented.

• The Inspector of Elections was appointed and confirmed the presence of a quorum, allowing the meeting to proceed.

• Voting was conducted virtually, with prior proxies honored unless changed during the meeting.

Board and executive committee updates

• Six director nominees were presented for election: Yuval Cohen, Rachelle Jacques, John Jenkins, Anne Altmeyer, Yong Ben, and Winston Kung.